- Home
- App Analytics
- AnticoagEvaluator
AnticoagEvaluator app analytics for December 19
AnticoagEvaluator
- American College of Cardiology
- Apple App Store
- Free
- Medical
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us
AnticoagEvaluator Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for AnticoagEvaluator
Rank
No Data Available
AnticoagEvaluator Ranking by Country
Counties in which AnticoagEvaluator has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Mayo Clinic Cardiovascular CME
Mayo Clinic
MAQI2 Anticoagulation Toolkit
The University of Michigan
Anticoagulation Manager
Centers for Disease Control and Prevention
EHRA Key Messages
Societe Europeenne de Cardiologie SEC
AnticoagEvaluator VS.
December 19, 2024